16 December 2025
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
Jubilant Flame International, Ltd
CIK: 1517389•2 Annual Reports•Latest: 2025-04-04
10-K / April 4, 2025
Revenue:N/A
Income:-$59,672
10-K / May 7, 2024
Revenue:N/A
Income:-$67,365
10-K / April 4, 2025
Company Summary: Jubilant Flame International, Ltd.
Overview
- Founded: September 29, 2009, under the name Liberty Vision, Inc.
- Incorporation: Nevada
- Current Name: Jubilant Flame International, Ltd. (since August 18, 2015)
- Location: Room 508, T1N Vi Park, 360 Xin Long Road, Shanghai, China, 201101
Business Activity and Evolution
- Initial Business: Provided web development and marketing services through a wholly owned subsidiary.
- Disposal of Subsidiary: In December 2012, the company disposed of this subsidiary.
- Original Focus: Developing and marketing medical products including Bone-Induction Artificial Bone and Vacuum Sealing Drainage under a BioMark license.
- Transition to Cosmetics: Starting in Q4 FY2018, the company began promoting and selling cosmetic products in the U.S., specifically the "Acropass" series.
- Products: Hydrocolloid patches with dissolving microstructures containing hyaluronic acid and epidermal growth factor (EGF).
- Sale Method: Sold directly online via own website and Amazon.
- Supplier: Rubyfield Holdings Limited (Chinese company owned by the CEO).
- Distribution: Managed through an agreement with a third-party manager, fulfilling orders in the U.S.
- Ceased Cosmetic Sales: Began in early 2020, with no revenue generated from cosmetics thereafter.
- New Business Focus (from 2020): Providing technical support services related to the development of nutritionally oriented foods.
- Products Supported: Sea-Buckthorn and Organic Sprouting Powder.
- Revenue: No revenue has been reported from this new business line as of FY2025.
Operations and Market
- Customer Base: No specific number of customers stated; sales were conducted online targeted toward U.S. consumers.
- Employees: 5 employees; primarily officers and directors managing operations.
- Revenue & Income:
- Revenue: $0 for FY2024 and FY2025.
- Net Loss:
- FY2024: $67,365
- FY2025: $59,672
- Market: The skincare and cosmetic market in the U.S. is highly competitive with large multinational competitors, smaller brands, and online skin care specialty sites.
Financial & Business Status
- Financial Condition:
- Total Assets (FY2025): $12,925
- Total Liabilities (FY2025): $1,369,510
- Working Capital Deficit: Approx. $1.36 million as of FY2025.
- No revenue from product sales in FY2025; primarily operational expenses.
- Loan: $763,424 owed to the CEO as of FY2025.
- Employees: No salaried employees other than officers and directors; no formal retirement or benefit plans.
- Regulatory: Products regulated under U.S. law (FD&C Act & FPLA) as cosmetics, but no premarket approval needed apart from color additives.
- Ownership & Stock:
- 19,985,708 shares outstanding as of April 2025.
- Mainly held by the company's officers and a few directors.
- No dividends paid or expected in the foreseeable future.
Summary of Key Activities
- Transitioned from medical device products to cosmetics, then ceased cosmetics sales.
- Currently offers technical support services for nutritionally oriented foods with no reported revenue.
- No current product sales, no active affiliates or distributors, and limited operational scale.
- Financially, it operates at a loss with minimal assets and significant liabilities primarily owed to the CEO and related parties.
Note: The company’s financials and operations indicate a small-scale, privately held enterprise focusing on niche product development and technical consulting rather than active product sales.
